Summary:
As the COVID-19 situation evolves and more information comes to hand, we will update this page with further medico-legal advice for members.
More than 4,500 accredited general practices will participate in Phase 1b of Australia’s COVID-19 rollout.
In Australia, as at 10 April 2021, over 1,166,000 vaccinations had been administered. This includes 142,067 Commonwealth vaccine doses being administered in aged care and disability facilities. The Australian Government Department of Health publishes the most recent figures on its website.
As GPs participating in the COVID-19 vaccine roll out are aware, there have been a range of logistical and clinical challenges associated with the rollout.
On 8 April 2021, the Australian Government noted further evidence of a rare but serious side effect involving blood clotting associated with thrombocytopenia (low platelet count) following administration of the COVID-19 AstraZeneca vaccine.
As a result, the Government announced the COVID-19 Pfizer vaccine is preferred over the COVID-19 AstraZeneca vaccine for adult patients under 50 years of age.
We would like to reassure our members that your Avant Practitioner Indemnity Insurance Policy is designed to cover you in both of the following scenarios (provided you have cover in an appropriate category of practice):
Please note that your Avant Practitioner Indemnity Insurance Policy is subject to the full terms, conditions and exclusions of the policy.
For more details, please see our frequently asked questions (FAQs) on this issue.
To assist doctors navigate the many challenges associated with the rollout, we have also compiled responses to members’ other FAQ on the COVID-19 vaccines to support our general COVID-19 FAQs, including:
Our other FAQs are located below and are updated regularly:
Updated: 13/4/2021
COVID-19: Resources: National
COVID-19: Resources: State and Territory
